SCHEMBL3148065

SCHEMBL3148065

CNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(C(C)(C)N)c1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
KCNK9 Q9NPC2 1/20 0.40
BACE1 P56817 2/20 0.39
KCNK3 O14649 1/20 0.39
MAPT P10636 3/20 0.38
NTRK1 P04629 1/20 0.38
NTRK3 Q16288 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.38
RXFP1 Q9HBX9 5/20 0.37
MAPK14 Q16539 1/20 0.37
KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3141980 0.91 KCNK9 (0.40) POLBCTDSP1KCNK9BACE1MAPT
SCHEMBL2571373 0.85 RXFP1 (0.46) POLBMAPTMEN1KMT2ATP53
SCHEMBL4504444 0.85 P2RX1 (0.40) POLBCTDSP1KCNK9KCNK3NTRK1
SCHEMBL5785822 0.85 CHEK1 (0.45) POLBCTDSP1KCNK9NTRK1NTRK3
SCHEMBL4505422 0.85 KDR (0.42) POLBCTDSP1KCNK9BACE1KCNK3
SCHEMBL5787515 0.84 MEN1 (0.41) POLBCTDSP1KCNK9KCNK3MAPT
SCHEMBL7464386 0.84 MEN1 (0.41) POLBCTDSP1KCNK9KCNK3MAPT
SCHEMBL4501471 0.83 RXFP1 (0.41) POLBCTDSP1MAPTMEN1KMT2A
SCHEMBL6327561 0.83 KMT2A (0.43) POLBKCNK9KCNK3MEN1KMT2A
SCHEMBL6326726 0.83 KMT2A (0.43) POLBKCNK9KCNK3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed